Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site. # Eos Bridging innovation with global opportunity ## Sitemaps - [XML Sitemap](https://eos-advisory.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [News Archive](https://eos-advisory.com/news-archive/) - Backing science, engineering and technology innovation that positively impacts our world. Founded in 2014, St Andrews, Scotland - [Bioliberty Raises $10.2 million to Build Functional Intelligence Capabilities for Post‑Acute Care](https://www.globenewswire.com/news-release/2026/03/19/3258693/0/en/Bioliberty-Raises-10-2-million-to-Build-Functional-Intelligence-Capabilities-for-Post-Acute-Care.html) - [Dxcover Secures CE-IVDR Certification](https://www.businesswire.com/news/home/20260303995618/en/Dxcover-Secures-CE-IVDR-Certification) - [Neupulse raises £3 million to accelerate delivery of its neurotherapeutic technology](https://neupulse.co/blogs/news/neupulse-raises-3-million-to-accelerate-delivery-of-its-neurotherapeutic-technology) - [New Blood Test Helps GPs Manage Brain Scan Delays, Brings Field Forward](https://www.businesswire.com/news/home/20260210021105/en/New-Blood-Test-Helps-GPs-Manage-Brain-Scan-Delays-Brings-Field-Forward) - Share - [Nami Surgical appoints Nikki Palfrey as CEO and completes latest investment round](https://www.namisurgical.com/2026/01/29/nami-surgical-appoints-nikki-palfrey-as-ceo-and-completes-latest-investment-round/) - [Wobble Genomics shares new data confirming ability to determine profiling of HER2 in tissue and blood](https://www.scientistlive.com/content/wobble-genomics-shares-new-data-confirming-ability-determine-profiling-her2-tissue-and-blood) - [Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis](https://www.businesswire.com/news/home/20251210618626/en/Chemify-Receives-an-Additional-Grant-to-Accelerate-Digital-Chemistry-Small-Molecule-Discovery-for-Tuberculosis) - Share - [Strathclyde Spinout Dxcover wins Deal of the Year (sub £10 Million) at the Insider Scotland Dealmakers Awards 2025](https://www.pressreader.com/uk/the-scotsman/20251120/282127822759967) - [CamGene Therapeutics Announces Seed Round to Advance RNA Therapeutics for Hearing Loss]() - [Deep-tech spinout Chemify raises $50 million](https://dailybusinessgroup.co.uk/2025/10/deep-tech-spinout-chemify-raises-50-million/) - [Eos leads £4.5M seed round into Ensilitech](https://www.eu-startups.com/2025/08/british-biotech-startup-ensilitech-raises-e5-2-million-to-cut-cold-chain-costs-in-biopharma-transport/) - [Laverock raises £20M+ in seed financing](https://www.laverocktx.com/news/laverock-therapeutics-expands-seed-funding-announces-key-milestone-progress) - [Dxcover Launches US Operations](https://www.businesswire.com/news/home/20250624175051/en/Dxcover-Launches-US-Operations-to-Commercialize-Its-AI-Powered-Multiomic-Cancer-Detection-Test) - [Chemify launch £12M Glasgow AI-facility](https://futurescot.com/new-ai-driven-chemistry-facility-in-glasgow-is-watershed-moment-for-global-drug-discovery-and-materials-science/) - [Naturbeads wins Best EIS Investee Company at the EISA Awards 2025](https://www.linkedin.com/posts/the-eis-association-limited_the-eisa-awards-2025-winners-ugcPost-7341577518220570625-oHzP/?utm_source=share&utm_medium=member_desktop&rcm=ACoAABh2x-QBTSzkUTRPluKedv4wbg7vzkmYXow) - [Bioliberty Launches Lifehub Clinic with Soft-Robotic Lifeglov](https://hitconsultant.net/2025/05/13/bioliberty-launches-lifehub-clinic-with-soft-robotic-lifeglov/) - [Portfolio company Dxcover presents evidence from brain cancer study](https://www.curetoday.com/view/larger-tumor-size-linked-to-higher-mortality-risk-in-brain-cancer) - [Wobble announces US Chair, Dr Dietrich Stephan](https://www.prnewswire.co.uk/news-releases/wobble-genomics-announces-appointment-of-dr-dietrich-a-stephan-as-chairman-of-the-board-of-directors-302446159.html) - [Ana Stewart becomes Chief Entrepreneur to Scottish Government](https://dailybusinessgroup.co.uk/2025/04/ana-stewart-to-become-unpaid-chief-entrepreneur/) - [Nami welcomes David O'Reilly as the corporate strategy advisor of its Board of Directors](https://www.namisurgical.com/2025/03/06/nami-welcomes-david-oreilly-as-the-corporate-strategy-advisor-of-its-board-of-directors/) - [Penrhos Bio builds international experience with new Chair](https://highgrowth.scot/scottish-biofilm-prevention-leader-remora-announces-international-business-expert-as-new-chair/) - [Eos leads £4.1M Dxcover round for US expansion](https://www.businesswire.com/news/home/20250203637724/en/Dxcover-Accelerates-Growth-With-New-Funding-Round-and-Strengthens-the-Leadership-Team) - [Eos leads £2.3m into AgTech company Biotangents](https://www.digit.fyi/biotangents-receives-2-3m-funding-for-diagnostic-device/) - [Eos leads £3m seed round into Concinnity Genetics](https://www.insider.co.uk/news/concinnity-genetics-raises-3-million-34319682) - [Eos leads £7.8m Series A into Naturbeads](https://www.businesswire.com/news/home/20241114197195/en/UK-Startup-Naturbeads-Secures-Series-A-Round-to-Further-Pioneering-Technology-That-Addresses-Worldwide-Microplastic-Pollution) - [Laverock makes significant advances in gene silencing platform](https://www.laverocktx.com/laverock-therapeutics-makes-significant-advances-in-its-unique-programmable-gene-silencing-platform-and-announces-pipeline-focus-on-advanced-therapies-in-oncology-and-genetic-diseases) - [Novosound Develops World’s First Ultrasound Blood Pressure Monitor](https://www.businesswire.com/news/home/20241028323651/en/Scottish-Tech-Company-Novosound-Develops-World’s-First-Ultrasound-Blood-Pressure-Monitor) - [Wobble announce breast cancer study at San Francisco conference](https://www.medicaldevice-network.com/news/wobble-genomics-debuts-tech-to-detect-rare-full-length-rna-transcript-variants/?cf-view) - [Chemify land significant grant from Gates Foundation](https://www.businesswire.com/news/home/20241001111190/en/Chemify-Receives-Grant-to-Design-and-Discover-New-Drug-Leads-for-Tuberculosis-and-Malaria-Using-Digital-Chemistry-Technology) - [Laverock makes significant advances](https://www.biospace.com/press-releases/laverock-therapeutics-makes-significant-advances-in-its-unique-programmable-gene-silencing-platform-and-announces-pipeline-focus-on-advanced-therapies-in-oncology-and-genetic-diseases) - [Carcinotech and Ishani win top awards at EISA](https://www.linkedin.com/feed/update/urn:li:activity:7209958739825565696/) - [Mark Beaumont in conversation on the Hardman podcast](https://hardmanandco.com/100-building-venture-firm-assessing-founders-and-science-based-investing-mark-beaumont-eos-advisory/) - [Nami Surgical secures £3.2 million led by Eos](https://www.morningstar.com/news/business-wire/20240508013293/nami-surgical-secures-investment-to-transform-robotic-assisted-surgery-market) - [Dxcover present clinical trial for the early detection of cancer at the American Association for Cancer Research](https://www.biospace.com/article/releases/dxcover-invited-to-present-its-create-2-clinical-trial-for-the-early-detection-of-colorectal-cancer-and-advanced-adenoma-at-the-american-association-for-cancer-research-annual-meeting-2024-in-san-diego-ca-april-10/) - [Neupulse secures a £2.5 million investment led by Eos](https://www.linkedin.com/posts/eos-advisory_neupulsehas-secured-funding-to-advance-the-activity-7175466945490620416-QmLQ?utm_source=share&utm_medium=member_desktop) - [Pathways Pledge Launch](https://www.digit.fyi/pathways-pledge-initiative-launches-with-first-signatories/) - [Carcinotech raises £4.2 million to expand into US](https://www.insider.co.uk/news/carcinotech-raises-42-million-expand-31989581) - [Green Bioactives partners Azelis for memory ingredient distribution](https://www.nutraingredients.com/Article/2023/11/24/green-bioactives-partners-azelis-for-memory-ingredient-distribution#) - [Eos leads £9m round into Cumulus Oncology](https://www.globenewswire.com/news-release/2024/01/08/2805065/0/en/Cumulus-Oncology-raises-9m-in-seed-financing.html) - [Bioliberty's meeting Princess Royal through their work with Leuchie House](https://www.linkedin.com/posts/mark-beaumont-47906728_delighted-to-attend-the-leuchie-house-royal-activity-7127574856182714368-0mrr/?utm_source=share&utm_medium=member_desktop) - [Collaborating in Scotland to accelerate a cure for brain tumours](https://www.thebraintumourcharity.org/news/policy-news/collaborating-in-scotland-to-accelerate-a-cure/#h-collaborating-with-dxcover) - [New executive hires to support growing portfolio](https://www.digit.fyi/scots-investment-firm-eos-makes-new-executive-appointments/) - [Featuring Rotimi Alabi from portfolio company RAB-Microfluidics, the Include & Inspire Business Series](https://scottishbusinessnews.net/knowvate-hub-launches-include-inspire-business-series/) - [On a mission to change the face of chemistry Chemify Limited with Lee Cronin speaking to Futurescot](https://futurescot.com/on-a-mission-to-change-the-face-of-chemistry/) - [Novosound announced major new trans Atlantic partnership](https://www.digit.fyi/novosound-inks-new-transatlantic-partnership/) - [10 Scottish Startups to Watch in 2024, featuring Chemify](https://techround.co.uk/news/10-scottish-startups-to-watch-in-2024/) - [Portfolio company Penhros Bio raise £3m growth round](https://www.digit.fyi/scottish-based-cleantech-bioscience-firm-raises-3-million/) - [Could Bio-Degradable Cellulose Beads Be the Future of CleanTech Manufacturing?](https://ukt.news/could-bio-degradable-cellulose-beads-be-the-future-of-cleantech-manufacturing/) - [European Society for Medical Oncology (ESMO) Congress 2023 award for Dxcover](https://www.expresshealthcaremgmt.com/news2/dxcover-awarded-first-prize-for-poster-at-esmo-2023-with-multi-omic-spectral-analysis-in-early-detection-of-multiple-cancers-data/199011/) - [Dxcover Aims for 2025 Debut of Brain Cancer Tests](https://www.360dx.com/cancer/dxcover-aims-2025-debut-brain-cancer-tests-adjustable-sensitivity-and-specificity) - [Dewpoint Therapeutics Partners with Chemify to apply ground-breaking Chemistry AI to radically accelerate the discovery of molecules](https://www.prnewswire.com/news-releases/dewpoint-therapeutics-partners-with-chemify-to-apply-groundbreaking-chemistry-ai-to-radically-accelerate-the-discovery-of-molecules-targeting-cancer-and-neurodegeneration-301923918.html#:~:text=Under the partnership, Chemify will,the compounds designed by Chemify) - [Congratulations Ishani Malhotra from Carcinotech for being a finalist in the EY Entrepreneur of the Year](https://www.ey.com/en_uk/entrepreneur-of-the-year/uk-finalists) - [Laverock raises £13.5m to commercialise gene editing induced gene silencing platform (GEiGS®)](https://www.pharmiweb.com/press-release/2023-09-28/laverock-therapeutics-raises-135m-to-develop-unique-gene-silencing-platform-for-programmable-advan) - [Eos portfolio company ENOUGH raises 40m euro scale-up equity investment](https://sifted.eu/articles/scottish-startup-enough-40m-for-alternative-meat-news?utm_source=sailthru&utm_medium=email&utm_campaign=flagship_newsletter&utm_content=21-08-23&utm_term=wants_main_newsletter) - [Glasgow firm Chemify raises £33m to 'digitise' chemistry](https://www.bbc.co.uk/news/uk-scotland-scotland-business-66376431) - [Carcinotech - How Bioprinting Can Improve Cancer Treatments](https://www.forbes.com/sites/evaepker/2023/07/11/26-million-new-cases-three-dimensions-and-one-new-technology-how-bioprinting-can-improve-cancer-treatments/?sh=50ab8de556b2) - [CNBC report about how ENOUGH, the Strathclyde spin-out and Eos portfolio company, thinks its fungi-based protein may be the solution to the unsustainable impact of sole reliance on traditional protein farming](https://www.youtube.com/watch?v=Y3kK4TW5vv8&ab_channel=CNBCInternational) - [British Business Investments commits £10m via its Regional Angels Programme](https://www.insider.co.uk/news/eos-secures-10-million-british-30277699) - [A warm welcome to Jill Arnold CA to the Eos team. As we continue to support impactful science and technology across Scotland and beyond, we really value the experience and vision that Jill brings to our work](https://www.digit.fyi/scots-investment-firm-eos-bolsters-portfolio-and-team-in-q1/) - [Welcoming Bioliberty to the Eos portfolio](https://www.insider.co.uk/news/bioliberty-secures-22-million-fund-29623940) - [Stewart demands government action on female entrepreneurship](https://www.insider.co.uk/news/stewart-demands-government-action-female-29405260) - [Significant growth round for Dxcover’s early stage cancer test](https://www.scotsman.com/business/glasgow-based-blood-test-pioneer-dxcover-secures-significant-seven-figure-funding-injection-4010453) - [Delighted to welcome Waire Health Ltd to the Eos portfolio](https://www.insider.co.uk/news/waire-health-scale-patient-monitoring-29025072) - [Ana Stewart talks to FutureScot about her work on the Scottish Government-commissioned evaluation into Women in Enterprise](https://futurescot.com/how-to-create-virbant-female-economy-at-heart-of-tech-entrepreneurs-women-in-enterprise-review/) - [Edinburgh’s Green Bioactives LTD Gains £2.6m Seed Funding](https://www.digit.fyi/edinburghs-green-bioactives-ltd-gains-2-6m-seed-funding/) - [Bye bye microbead plastic pollution - the new website from Naturbeads - Eos is proud to be backing their growth](https://www.naturbeads.com/) - [SEIS limit increased to £250k](https://eisa.org.uk/news_story/eis-extended-beyond-sunset-clause-and-seis-limits-increased/) - [Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets](https://www.globenewswire.com/news-release/2022/09/06/2510010/0/en/Nodus-Oncology-launches-founded-by-Cumulus-Oncology-and-in-partnership-with-the-Lead-Discovery-Center-to-focus-on-developing-first-and-best-in-class-molecules-inhibiting-novel-DNA-.html) - [Cleantech Startup Penrhos Bio Raises £1m with Support from Eos](https://www.digit.fyi/penrhos-bio-funding/) - [Eos portfolio company, RAB-Microfluidics gets £2.2 million to scale-up oil analysis device](https://www.insider.co.uk/news/scottish-tech-firm-gets-22-27872778) - [Eos portfolio company, Cumulus Oncology is the first oncology drug development accelerator in Europe.](https://www.linkedin.com/posts/the-eis-association-limited_scale-up-spotlight-cumulus-oncology-activity-6965658188390002688-P40b?utm_source=share&utm_medium=member_desktop) - [Eos is supporting Ready Steady Grow! 2022](https://www.eventbrite.co.uk/e/ready-steady-grow-2022-edinburgh-tickets-379649681417) - [Spin-out company aiming to replace harmful plastic microbeads receives £1.3M investment](https://www.eurekalert.org/news-releases/957283) - [Andrew Durkie has joined Eos as a Partner alongside Andy Lothian and Sandy Kennedy as Growth Advisors as we work to support our portfolio of high impact companie](https://www.insider.co.uk/appointments/eos-advisory-appoints-former-hbos-27215373) - [Carcinotech secures £1.6m funding to support international growth backed in-part by Eos Advisory](https://www.insider.co.uk/news/carcinotech-secures-16-million-funding-26788696) - [St Andrews' Eos Advisory portfolio tops £121m](https://www.heraldscotland.com/business_hq/19906181.st-andrews-eos-advisory-portfolio-tops-121m/) - [Cumulus Oncology Secures £4.1m ($5.6m) Investment Led by Eos Advisory](https://www.businesswire.com/news/home/20220222005245/en/Cumulus-Oncology-Secures-£4.1m-5.6m-Investment-Led-by-Eos-Advisory#new_tab) - [Eos portfolio company Rooser raises $23M for its seafood trading platform](https://techcrunch.com/2022/04/24/fishy-business-rooser-raises-23m-for-its-seafood-trading-platform/?guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACm9g3kpxVlLv-tpeFvzCjZ_t8OIFXZJY-TBPu63BKA0Ch8VKaRXuYfrOipkPxH4n6jtx1sHwmELS4UVCWI1nHvAKY5305n5BGXEVvSDb9OsQaHaxZV0NwDZR3OkrS_5lwbINT-8giwPSZ4Nuyd5F3WtCOjyd661SSSzHW8QdGgd&guccounter=2) - [Investing for impact – St Andrews firm Eos wants to make ‘positive’ difference](https://www.thecourier.co.uk/fp/business-environment/2805525/investing-for-impact-st-andrews-firm-eos-wants-to-make-positive-difference/) - [Speaking with the IFA Magazine - as we launch the Eos Advisory EIS Innovation Fund into the IFA market.](https://ifamagazine.com/article/introducing-a-powerful-new-name-in-eis-investing-eos-advisory/#new_tab) - [Wobble Genomics appoints two high-profile non-executive directors](https://www.insider.co.uk/appointments/wobble-genomics-appoints-two-high-25264449#new_tab) - [Scottish start-ups that are focussed on impact around climate change, energy solution and also food & water security.](https://futurescot.com/the-green-tech-power-list/#new_tab) - [Portfolio company ILC Therapeutics Ltd completes £3.5m funding round - to be used to accelerate development of hybrid interferon designed to combat viral infections in a round including Los Angeles-based lawyer and investor Robert Kopple; Eos Advisory; Scottish Enterprise; and members of ILCT's management](https://www.insider.co.uk/news/ilc-therapeutics-completes-35-million-24917980) - [Wobble Genomics hails £1.2m investment round led by Eos Advisory](https://www.scottishfinancialnews.com/article/wobble-genomics-hails-1-2m-investment-round-led-by-eos-advisory) - [The recently rebranded Dxcover have been back in the press - taking about a study which has been hugely successful in identifying tumours as small as 0.2cm from a simple blood test - which has been hailed as “transformative” for patients and doctors.](https://www.heraldscotland.com/news/19494301.glasgow-firm-behind-transformative-blood-test-can-identify-brain-tumours-early-stages/) - [Growth funding round by Chromacity Ltd to expedite international growth, especially in Asia. This £1.2m round included investment from Eos Advisory, Kelvin Capital, ESM INVESTMENTS LIMITED and Scottish Enterprise.](https://www.insider.co.uk/news/laser-tech-business-chromacity-secures-24733491?utm_source=business_insider_newsletter&utm_campaign=daily_newsletter2&utm_medium=email) - [ENOUGH raises €42m ($51M) Series B to supercharge sustainable protein](https://www.enough-food.com/news-series-b) - [Chromacity founder and CEO Shahidi Imani talks about leadership in ElectroOptic magazine](https://www.electrooptics.com/analysis-opinion/leading-example) - [Eos portfolio business ClinSpec DX focused on the early detection of cancer has received a major seven-figure funding injection](https://www.scotsman.com/business/strathclyde-uni-spinout-advancing-cancer-detection-secures-multi-million-funding-injection-2963648) - A University of Strathclyde spinout business focused on the early detection of cancer has received a major seven-figure funding injection. Glasgow-based ClinSpec Diagnostics (ClinSpec Dx), which was spun out from the university’s department of pure and applied chemistry in 2016, has developed a way of detecting cancer at an early stage using a simple blood - [M&S and Eos portfolio business 3F BIO collaborate for mycoprotein vegan range](https://www.foodnavigator.com/Article/2020/11/18/M-S-and-3F-BIO-collaborate-for-mycoprotein-vegan-range) - [Edinburgh based Cumulus Oncology appoints Nicola Broughton, Chris Brinsmead, Mohamed Raza (Raz) Dewji and Ian Waddell to their advisory board](https://www.insider.co.uk/appointments/edinburgh-based-cancer-treatment-accelerator-23052480?utm_source=business_insider_newsletter&utm_campaign=daily_newsletter2&utm_medium=email) - [Mark Beaumont joins the Eos executive leadership team](https://www.scotsman.com/business/record-breaking-cyclist-mark-beaumont-takes-top-role-fife-investment-firm-3048045) - [ILC Therapeutics announces significant and first international investor Medical Incubator Japan (MIJ) in a round that includes further investment from Eos](https://www.globalbankingandfinance.com/category/news/uk-biotech-company-ilc-therapeutics-announces-first-international-investment/) - [‘Lab on a chip’ technology company RAB Microfluidics completes £1.24 million investment round lead by Eos Advisory](https://www.insider.co.uk/news/scottish-rd-startup-secures-124-23262566) - [Digital Sports Arena (DSA) signs global publishing deal with Playstack](https://www.insider.co.uk/news/dundee-based-video-game-developer-23336731) - [Scotland gets top marks for producing University spin outs](https://www.scotsman.com/business/scotland-gets-top-marks-producing-university-spin-outs-3107212) - [Chris Brinsmead CBE joins the Eos partnership](https://www.insider.co.uk/appointments/former-astrazeneca-executive-joins-eos-23378477) - [Eos launches trans-Atlantic Venture partnership with Kineticos Disruptor Fund](https://www.bbc.co.uk/news/uk-scotland-scotland-business-56048487) - [Eos portfolio Cumulus Oncology eyes further growth as US office is set to open this year](https://www.scottishfinancialnews.com/article/greenshoots-cumulus-oncology-eyes-further-growth-as-us-office-is-set-to-open-this-year) - [ClinSpec Diagnostics Limited (ClinSpec Dx) reaches its round two funding target of £3.5 million from Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders.](https://www.scottishfinancialnews.com/article/clinspec-diagnostics-limited-completes-3-5m-funding-round) - [Cumulus Oncology launches partnership with Lead Discovery Center GmbH – an exciting next chapter for this pioneering Eos portfolio company](https://www.insider.co.uk/news/edinburgh-pharmaceutical-company-agrees-partnership-23771000) - [A short video from the team at Chromacity explaining how they are transforming the industrial laser market](https://chromacitylasers.com/why-chromacity/about-us/) - Video Link - [Eos portfolio business ClinSpec DX secures a further £2.4m in Funding for Early Cancer Detection Tech](https://digit.fyi/clinspec-secures-2-4m-in-funding-for-early-cancer-detection-tech/) - The Glasgow-based company is hoping to use the funding to support further development of testing technology. ClinSpec Diagnostics Limited (ClinSpec Dx) has secured £2.4 million in investment from an Eos lead syndicate to help develop a new technology that can detect cancer at an early stage using blood tests. The ClinSpec Dx blood test uses - [Eos portfolio business, the cancer drug discovery accelerator Cumulus Oncology, launches its first spinout – Modulus Oncology](https://www.insider.co.uk/news/edinburgh-pharmaceutical-company-agrees-partnership-23771000) - The move is the first of many with the aim of creating a major new force in Scottish biotech Cancer drug discovery accelerator Cumulus Oncology has become a key founder of start-up biotech company, Modulus Oncology. Edinburgh-based Cumulus is backing Modulus, a University of Sheffield spinout company that focuses on hard-to-treat cancers. Modulus is the ## Pages - [Home](https://eos-advisory.com/) - Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives. - [Portfolio](https://eos-advisory.com/portfolio/) - A growing & thriving portfolio. Meet our inspiring founders. Companies are defined by people and their performance. - [Team](https://eos-advisory.com/team/) - The Eos team is made up of founders, scientists, record breakers, industry leaders, and government advisors. - [Risk Warnings](https://eos-advisory.com/risk-warnings/) - Important Information Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk. What are the key risks? 1. You could lose all the money you invest If the business you invest in fails, you are likely to lose 100% of the money you invested. Most start-up businesses - [Cookies](https://eos-advisory.com/cookies/) - Cookie Policy Last updated April 12, 2023 ABOUT THIS COOKIE POLICYEos Advisory LLP (“Company“, “we“, “us“, “our“) may use cookies when you visit our website Eos Advisory LLP, including any other media form, media channel, mobile website, or mobile application related or connected thereto (collectively, the “Site”) to help customize the Site and improve your - [Privacy Policy](https://eos-advisory.com/privacy-policy/) - Privacy Policy Last updated April 12, 2023 Contents ABOUT THIS PRIVACY POLICYEos Advisory LLP (“Company“, “we“, “us“, “our“) is a limited liability partnership incorporated in Scotland (company number SO306577) with its registered office at Kinburn Castle, Doubledykes Road, St Andrews, KY16 9DR. We are committed to protecting your personal information and your right to privacy. ## Categories - [Uncategorized](https://eos-advisory.com/category/uncategorized/) - [insider](https://eos-advisory.com/category/insider/) - [DIGIT](https://eos-advisory.com/category/digit/) - [The Scotsman](https://eos-advisory.com/category/the-scotsman/) ## Featured - [yes](https://eos-advisory.com/featured/yes/) ## Group - [Investment Committee](https://eos-advisory.com/group/investment-committee/) ## Display Order - [1st Line](https://eos-advisory.com/line-order/first-line/) - [2nd Line](https://eos-advisory.com/line-order/second-line/) - [3rd Line](https://eos-advisory.com/line-order/third-line/) - [4th Line](https://eos-advisory.com/line-order/4th-line/)